Skip Navigation LinksHome > June 2013 - Volume 56 - Issue 2 > Myasthenia Gravis and Pregnancy
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e31828e92c0
Neurologic Diseases in Pregnancy: An Overview

Myasthenia Gravis and Pregnancy


Collapse Box


Myasthenia gravis is an autoimmune disease of the neuromuscular junction characterized by painless fluctuating skeletal muscle weakness. Disease exacerbations are more likely to occur in the first trimester or puerperium. A number of medications commonly used in obstetric practice can exacerbate the disease. The effect of pregnancy on myasthenia varies substantially from woman to woman and also from pregnancy to pregnancy in the same woman. Mainstay treatments involve acetylcholine esterase inhibitors, corticosteroids and other immunosuppressants, and adequate rest. Newborns may suffer in utero or neonatal consequences, usually transient, of transplacental antibody exposure.

© 2013 by Lippincott Williams & Wilkins.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.